Titre:
  • Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Auteur:Proost, P; Schutyser, Evemie; Menten, P; Struyf, Sofie; Wuyts, A; Opdenakker, G; Detheux, Michel; Parmentier, Marc; Durinx, C; Lambeir, A M; Neyts, Johan; Liekens, S; Maudgal, P C; Billiau, A; Van Damme, Jo
Informations sur la publication:Blood, 98, 13, page (3554-3561)
Statut de publication:Publié, 2001-12
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Angiogenesis Inhibitors -- chemistry
Angiogenesis Inhibitors -- pharmacology
Antigens, CD26 -- metabolism
Calcium -- metabolism
Chemokine CXCL10
Chemokine CXCL11
Chemokine CXCL9
Chemokines, CXC -- chemistry
Chemokines, CXC -- metabolism
Chemokines, CXC -- pharmacology
Chemotaxis, Leukocyte -- drug effects
Intercellular Signaling Peptides and Proteins
Lymphocytes -- physiology
Receptors, CXCR3
Receptors, Chemokine -- agonists
Receptors, Chemokine -- physiology
Signal Transduction -- drug effects
Structure-Activity Relationship
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:pmid/11739156